Familial Cancer

杂志介绍

Familial Cancer杂志介绍

《Familial Cancer》是一本以English为主的未开放获取国际优秀期刊，中文名称家族性癌症，本刊主要出版、报道医学-GENETICS & HEREDITY领域的研究动态以及在该领域取得的各方面的经验和科研成果，介绍该领域有关本专业的最新进展，探讨行业发展的思路和方法，以促进学术信息交流，提高行业发展。该刊已被国际权威数据库SCIE收录，为该领域相关学科的发展起到了良好的推动作用，也得到了本专业人员的广泛认可。该刊最新影响因子为1.8，最新CiteScore 指数为4.1。

本刊近期中国学者发表的论文主要有：

• Polymorphisms in arachidonic acid metabolism-related genes and the risk and prognosis of colorectal cancer

  Author: Shuying Li, Xiaojuan Zhao, Zhiwei Wu, Ye Li, Lin Zhu, Binbin Cui, Xinshu Dong, Suli Tian, Fulan Hu, Yashuang Zhao

• Association of interleukin-23 receptor gene polymorphisms with risk of bladder cancer in Chinese

  Author: Tielong Tang, Hui Xue, Shu Cui, Zhiyong Gong, Zhonghai Fei, Shulin Cheng, Chunyan Gui

• Genetic 135G/C polymorphism of <Emphasis Type="Italic">RAD51</Emphasis> gene and risk of cancer: a meta-analysis of 28,956 cases and 28,372 controls

  Author: Bei-bei Zhang, Dao-gang Wang, Chao Xuan, Gui-li Sun, Kai-feng Deng

• Mitochondrial membrane potential and reactive oxygen species in cancer stem cells

  Author: Bei-bei Zhang, Dao-gang Wang, Fen-fen Guo, Chao Xuan

英文介绍

Familial Cancer杂志英文介绍

In recent years clinical cancer genetics has become increasingly important. Several events, in particular the developments in DNA-based technology, have contributed to this evolution. Clinical cancer genetics has now matured to a medical discipline which is truly multidisciplinary in which clinical and molecular geneticists work together with clinical and medical oncologists as well as with psycho-social workers.

Due to the multidisciplinary nature of clinical cancer genetics most papers are currently being published in a wide variety of journals on epidemiology, oncology and genetics. Familial Cancer provides a forum bringing these topics together focusing on the interests and needs of the clinician.

The journal mainly concentrates on clinical cancer genetics. Most major areas in the field shall be included, such as epidemiology of familial cancer, molecular analysis and diagnosis, clinical expression, treatment and prevention, counselling and the health economics of familial cancer.